Introduction {#sec1}
============

The *NBN* gene product (nibrin) is part of the MRE11/RAD50/NBN (MRN) complex, which plays an essential role in genomic stability \[[@cit0001]\]. This complex is involved in DNA double-strand break (DSB) repair, telomere maintenance and meiotic recombination. Moreover, it recognizes DNA damage and takes part in the control of cell cycle checkpoints and apoptosis. *NBN* gene mutations, both homozygous and heterozygous, affect the proper function of nibrin, resulting in impaired activity of the MRE11/RAD50/NBN complex and consequently leading to carcinogenesis \[[@cit0002]\]. Homozygous c.657-661del mutation of the *NBN* gene causes Nijmegen breakage syndrome (NBS), in the course of which there is a high susceptibility to lymphatic system cancer and brain tumours \[[@cit0003]--[@cit0005]\]. Nijmegen breakage syndrome patients, having a higher rate of spontaneous chromosome breakage, are very sensitive to radiation, and more than 40% of them develop lymphomas before the age of twenty. The best known heterozygous *NBN* gene mutations considered to be minor cancer risk factors involve c.657-661del, p.I171V and p.R215W \[[@cit0002], [@cit0006], [@cit0007]\]. These mutations have been found in 2--9% of patients with breast, cervical, prostate, larynx and colorectal cancer, as well as lymphoid neoplasms and brain tumours \[[@cit0002], [@cit0005]\]. Our own results indicate a p.I171V mutation, in particular, as a potential risk factor for cancer in adults and leukaemia in children \[[@cit0004], [@cit0006], [@cit0007]\].

The link between chromosomal instability and increased radiosensitivity of cells bearing the homozygous c.657-661del mutation of the *NBN* gene is well established \[[@cit0008]--[@cit0010]\]. However, there are no conclusive data regarding the effects of radiation on cells with the above-mentioned heterozygous mutations of the *NBN* gene. Therefore, the aim of this study was to answer the following question: What is the effect of irradiation on DNA synthesis inhibition, *NBN* gene expression and chromosomal stability in lymphoblastic cell lines with germinal homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W *NBN* gene mutations?

Material and methods {#sec2}
====================

Cells {#sec2.1}
-----

The study was conducted on a lymphoblastic cell line derived from B-lymphocytes immortalized by the Epstein-Barr virus (EBV). B-lymphocytes with germinal *NBN* gene mutations (homozygous c.657-661del, heterozygous c.657-661del, p.I171V and p.R215W) were obtained from patients with acute lymphoblastic leukaemia (ALL) in remission diagnosed at the Department of Paediatric Oncology, Haematology and Bone Marrow Transplantation at the Poznan University of Medical Sciences \[[@cit0004]\]. Immortalized B-lymphocytes from healthy individuals, without the above-mentioned *NBN* gene mutations in exons 5 and 6, were used as the control. The Poznan University of Medical Sciences Ethics Committee approved the study.

Cell immortalization {#sec2.2}
--------------------

Peripheral blood lymphocytes (PBL) from patients and healthy individuals were isolated by Histopaque-1077 (Sigma-Aldrich, Steinheim, Germany) gradient centrifugation (1.077 g/ml). The washed cells were suspended as 2 × 10^6^ cells/ml in RPMI-1640 (Sigma-Aldrich, Steinheim, Germany) medium supplemented with 20% fetal bovine serum (FBS) (Sigma-Aldrich, Steinheim, Germany), 2 µg/ml cyclosporine A (Sigma-Aldrich, Steinheim, Germany), and 10% EBV-containing medium. Cells were cultured for 3 weeks at 37°C in a 5% CO~2~ atm. Afterwards, the immortalized cells were propagated in RPMI-1640 medium supplemented with 15% FBS and penicillin/streptomycin (Sigma-Aldrich, Steinheim, Germany).

Irradiation {#sec2.3}
-----------

Immortalized cells were X-ray irradiated at doses of 1, 2, 5 and 8 Gy/min using a Gammacell 1000 ^137^Cs irradiator.

Cell viability {#sec2.4}
--------------

Cell viability was assessed using the propidium iodide (PI) exclusion test and was analysed by flow cytometry with vision (FACS Scan, Becton Dickinson, New York, NY, USA). One million cells were stained and 2 × 10^4^ cells were counted in each sample. The percentage of live cells (PI negative) was calculated by FACSDiva software. Viability of cells was measured in three independent experiments.

DNA synthesis {#sec2.5}
-------------

Radioresistant DNA synthesis was measured by ^3^H thymidine (American Radiolabeled Chemicals, St. Louis, MO, USA) incorporation assay. Briefly, 20 µl of ^3^H thymidine at activity 2 µCi/ml was added to each microplate well containing 2 × 10^5^ analysed cells. Then, cells were harvested on a Flow Laboratories appliance 3, 24 and 48 h after irradiation. ^3^H thymidine incorporation was counted using a Rackbeta liquid scintillation counter (LKB Wallac, Mt Waverley, Vic, Australia). The results were presented as counts per minute (cpm). Additionally, the DNA synthesis rate and the percentage of cells in phase S of the cell cycle were analysed using the 5-bromo-2-deoxyuridine (BrdU) incorporation assay (EZ-BrdU, Phoenix Flow System, San Diego, CA, USA). All steps of the procedure and analysis of the results were performed according to the manufacturer's protocol. Briefly, the cells were incubated for 1 h in the presence of BrdU, then were permeabilized and washed twice. After DNA denaturation cells were stained with anti-BrdU antibody conjugated with fluorescein and cellular DNA was stained using PI. The fluorescence from PI and fluorescein was measured for 2 × 10^4^ cells in each sample. The percentage of actively replicating cells was calculated using FACSDiva and Cyflogic software. ^3^H thymidine and BrdU incorporation were measured in three independent experiments.

*NBN* gene expression {#sec2.6}
---------------------

Real-time PCR with specific primers and a FAM/TAMRA labelled probe localized in exons 8 and 9 in the *NBN* gene was applied for analysis of *NBN* gene expression. The primers and probe sequences for *NBN* and *B2M* (β2-microglobulin, reference gene) are presented in [Table I](#t0001){ref-type="table"}. *NBN* gene expression was analysed prior to and 3, 24 and 48 h after irradiation. In non-irradiated cells, the relative expression was calculated according to the following formula: *R* = 2^--dCt^ = 2^--\[Ct(*NBN*)\ --\ Ct(*B2M*)\]^. The relative expression after irradiation was calculated according to the following formula: 2^--ddCt^ = 2^--\[(Ct\ *NBN*\ --\ Ct\ *B2M*)dose\ --\ (Ct\ *NBN-Ct\ B2M*)0Gy\]^. Expression was measured in three independent experiments and each reaction was run in triplicate.

###### 

Primers and probe sequences and their localization according to NCBI Reference Sequence NM_002485.4 for Homo sapiens nibrin (*NBN*) (product length 128 bp) and NM_004048.2 for Homo sapiens β2-microglobulin (*B2M*) (product length 98 bp)

  Primer               Sequence                        Localization   Exon
  -------------------- ------------------------------- -------------- ------
  *NBN* F Primer       GATCCTCAGGGCCATCCC              1080--1097     8
  *NBN* R Primer       TCAGCTACGTATGTTGTAGTGTTCA       1183--1207     9
  *NBN* TaqMan probe   ACAACAAGTCCAGGACCAAGCCTTT       1113--1137     9
  *B2M* F Primer       TGCCGTGTGAACCATGTGA             358--376       2
  *B2M* R Primer       CCAAATGCGGCATCTTCA              438--455       3
  *B2M* TaqMan probe   TGATGCTGCTTACATGTCTCGATCCCACT   401--429       3

Cytogenetic analysis {#sec2.7}
--------------------

Chromosomal aberrations were assessed prior to as well as 24 h after irradiation of cultured cells with doses of 5 Gy. Chromosome analysis was carried out in harvested cells 3 h after the addition of 0.1 µg/ml colcemid (PAN-Biotech, Aidenbach Germany). Standard air-dried preparations and 5% Giemsa staining were performed.

Chromosome aberrations were scored in 80--100 metaphases (approx. 40--50 cells from two independent experiments) for each cell line. Analysed chromosome aberrations included: chromatid gaps, chromatid breaks, chromosome gaps, chromosome breaks, dicentric chromosomes, and triradial and tetraradial figures. The results are given as the number of chromosomal aberrations per metaphase.

Statistical analysis {#sec2.8}
--------------------

The results obtained were compared using a two-tailed Fisher's exact test as well as a two-tailed Student's test. The differences were considered significant if the value of probability (*p*) was less than 0.05. Analysis was undertaken using the JMP program from the SAS Institute Inc., version 11.0.0.

Results {#sec3}
=======

Cell viability {#sec3.1}
--------------

Cell viability measured before irradiation as well as 3 h after irradiation with a dose of 1 Gy was comparable in all cell lines tested. After high-dose irradiation, the highest sensitivity was found in the cell line with homozygous c.657-661del. Three hours after irradiation with dose of 2, 5 and 8 Gy these cells showed significantly lower viability compared to the control cell line (all *p*-values \< 0.0001), whereas viability of the other cell lines tested was comparable with the control ([Figure 1](#f0001){ref-type="fig"}).

![Viability of cells with *NBN* gene mutations (homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W) and control cells measured 3 h after irradiation with doses of 1 Gy, 2 Gy, 5 Gy and 8 Gy by propidium iodide exclusion test. 0 Gy: non-irradiated cells; control: cell line without *NBN* gene mutations; \**p* \< 0.0001. Viability was measured in three independent experiments. Results were normalized to 100% and expressed as mean ± SD](AMS-13-29240-g001){#f0001}

DNA synthesis {#sec3.2}
-------------

There was no statistically significant difference in ^3^H thymidine incorporation 3 h after irradiation with regard to the dose of irradiation in each studied cell line. However, in all cell lines, including the control, a decrease in ^3^H thymidine incorporation with increasing doses of irradiation was observed ([Figure 2 A](#f0002){ref-type="fig"}). A significant decrease in ^3^H thymidine incorporation was noted in all irradiated cells after 24 h of culture ([Figure 2 B](#f0002){ref-type="fig"}). The most pronounced decrease of ^3^H thymidine incorporation was found both in homozygous and heterozygous c.657-661del cells. Increasing the irradiation dose resulted in a decrease in ^3^H thymidine incorporation in all cell lines, but was statistically significant only when comparing irradiated (1, 2, 5 and 8 Gy) with non-irradiated (0 Gy) cells (all *p*-values \< 0.0001). After 48 h of culture a significant gradual decrease in ^3^H thymidine incorporation was only observed in homo- and heterozygous c.657-661del cell lines (both *p*-values \< 0.0001). In other cell lines, irradiation did not significantly affect radioresistant DNA synthesis ([Figure 2 C](#f0002){ref-type="fig"}). Non-irradiated homo- and heterozygous c.657-661del cell lines showed the highest levels of DNA synthesis as measured by ^3^H thymidine incorporation in comparison to other cell lines (all *p*-values \< 0.001). Moreover, after irradiation, these cell lines showed the highest incorporation of ^3^H thymidine. This highest DNA synthesis was most evident after 24 and 48 h of culture.

![Radioresistant DNA synthesis measured as 3H thymidine incorporation 3 h (**A**), 24 h (**B**) and 48 h (**C**) after irradiation of cell lines with *NBN* gene mutations (homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W) and control cell line with doses of 1 Gy, 2 Gy, 5 Gy and 8 Gy. ^3^H thymidine incorporation was counted in three independent experiments. Results are presented as the mean value of counts per minute (cpm) ± SD. 0 Gy: non-irradiated cells; control: cell line without *NBN* gene mutations](AMS-13-29240-g002){#f0002}

Additionally, the DNA synthesis rate and percentage of replicating cells were measured using the BrdU incorporation assay. At 3 h after irradiation with a dose of 2 and 8 Gy cells with the homozygous c.657-661del mutation showed the highest level of BrdU incorporation -- percentage of cells in synthesis (S) phase -- compared to the control (*p* = 0.0064 and *p* = 0.0042 for 2 Gy and 8 Gy, respectively) and other cell lines tested (*p* = 0.0057 and *p* = 0.0038 for heterozygous c.657-661del cell line, *p* = 0.0090 and *p* = 0.0062 for p.R215W cell line, *p* = 0.0083 and *p* = 0.0056 for p.I171V cell line) ([Figures 3](#f0003){ref-type="fig"} and [4](#f0004){ref-type="fig"}). The cell lines with heterozygous *NBN* gene mutations (c.657-661del, p.R215W and p.I171V) exhibited a percentage of cells in S-phase similar to the control cell line ([Figures 3](#f0003){ref-type="fig"} and [4](#f0004){ref-type="fig"}).

![Percentage of cells in phase S of the cell cycle measured as 5-bromo-2-deoxyuridine incorporation 3 h after irradiation of cell lines with *NBN* gene mutations (homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W) and control cell line with doses of 2 Gy and 8 Gy. 0 Gy: non-irradiated cells; control: cell line without *NBN* gene mutations; \**p* \< 0.01. BrdU incorporation was measured in three independent experiments. Results were normalized to 100% and expressed as mean ± SD](AMS-13-29240-g003){#f0003}

![Cell cycle pattern before (0 Gy) and after irradiation (8 Gy) of cell lines with *NBN* gene mutations (homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W) and control cells (cell line without *NBN* gene mutations). X-axis: fluorescence for propidium iodide; Y-axis: fluorescence for fluorescein](AMS-13-29240-g004){#f0004}

*NBN* gene expression {#sec3.3}
---------------------

The next step of our study was to establish whether homozygous and heterozygous mutations of the *NBN* gene affect expression of this gene. *NBN* gene expression was studied in non-irradiated cell lines established from B-lymphocytes of homo- and heterozygous carriers of *NBN* gene mutations, as well as in the control cell line ([Figure 5](#f0005){ref-type="fig"}). Cells with homozygous and heterozygous c.657-661del mutations as well as p.I171V mutation showed lower relative *NBN* gene expression compared to the control (*p* = 0.165 and *p* = 0.002, *p* = 0.004 respectively). Significantly higher *NBN* gene expression, compared to the control, was found in the p.R215W cell line (*p* = 0.005) ([Figure 5](#f0005){ref-type="fig"}).

![Relative NBN gene expression in non-irradiated cell lines with NBN gene mutations (homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W) and in control (cell line without NBN gene mutations). NBN gene expression is shown in relation to B2M gene expression (β2-microglobulin, reference gene). Relative gene expression (R) was calculated using the formula: R = 2^--\[dCt\ (*NBN*)-dCt\ (*B2M*)\]^. Expression was measured in three independent experiments and each reaction was run in triplicate. The results were expressed as the mean of R ± SD; \*p \< 0.05](AMS-13-29240-g005){#f0005}

Subsequently, immortalized cells with *NBN* gene mutations were irradiated with 1--8 Gy and *NBN* expression was measured after 3, 24 and 48 h of culture ([Figures 6 A--D](#f0006){ref-type="fig"}). Three hours after irradiation the highest increase in *NBN* gene expression in homozygous c.657-661del and heterozygous p.R215W cells was observed. The relative expression of *NBN* was significantly higher in homozygous c.657-661del and heterozygous p.R215W cells as compared to heterozygous c.657-661del (*p* = 0.0017 and *p* = 0.002, respectively) and p.I171V cells (*p* = 0.0015 and *p* = 0.0017, respectively), as well as to the control (*p* = 0.002 and *p* = 0.0023, respectively). With an increasing radiation dose, a systematic but insignificant decrease in relative expression of *NBN* in all cell lines was observed. Similarly, *NBN* gene expression after irradiation decreased with the time of culture. When comparing 3- and 48-hour culture in all cell lines, a significant decrease in *NBN* expression was demonstrated (all *p*-values \< 0.001) ([Figures 6 A--D](#f0006){ref-type="fig"}).

![Relative *NBN* gene expression in cell lines with *NBN* gene mutations (homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W) and in control (cell line without *NBN* gene mutations) after irradiation with 1 Gy (**A**), 2 Gy (**B**), 5 Gy (**C**) and 8 Gy (**D**) in 3-, 24-, and 48-hour culture. *NBN* gene expression in each cell line is shown in relation to non-irradiated cells (0 Gy). Relative gene expression (*R*) was calculated using the formula: *R* = 2^--\[ddCt\ *NBN*\ (0Gy\ --\ doseGy)\ --\ ddCt\ *B2M*\ (0Gy\ --\ doseGy)\]^. Expression was measured in three independent experiments and each reaction was run in triplicate. The results were expressed as the mean of R ± SD](AMS-13-29240-g006){#f0006}

Chromosomal stability {#sec3.4}
---------------------

Chromosomal aberrations were assessed prior to and 24 h after irradiation with 5 Gy. The highest total number of chromosomal aberrations per metaphase before irradiation was observed in the homozygous c.657-661del cell line (all *p*-values \< 0.001). The total number of chromosomal aberrations was also high in the heterozygous c.657-661del cell line ([Figure 7 A](#f0007){ref-type="fig"}).

![Chromosomal aberrations in cell lines with *NBN* gene mutations (homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W) and control cell line prior to irradiation (0 Gy, **A**) and 24 h after irradiation with 5 Gy (**B**). The occurrence of one or two chromatid gaps, one or two chromatid breaks, dicentric chromosomes, and triradial and tetraradial figures was assessed. The results are given as the mean number of chromosomal aberrations per metaphase. Chromosome aberrations were scored in 80--100 metaphases (approx. 40--50 cells from two independent experiments) for each cell line. Control: cell line without *NBN* gene mutations. Results were expressed as mean number of chromosomal aberrations per metaphase ± SD](AMS-13-29240-g007){#f0007}

The number of chromosomal aberrations increased in each cell line after irradiation ([Figure 7 B](#f0007){ref-type="fig"}). Moreover, after irradiation, all cell lines with *NBN* gene mutations showed a significantly higher total number of chromosomal aberrations per metaphase as compared to the control cell line (all *p*-values \< 0.001). The highest total number of chromosomal aberrations, compared to the control cell line, was observed in homozygous c.657-661del cell lines (*p* \< 0.001) ([Figure 7 B](#f0007){ref-type="fig"}). An example of metaphase of a cell with a homozygous c.657-661del mutation after irradiation is shown in [Figure 8](#f0008){ref-type="fig"}.

![Metaphase of cell with homozygous c.657-661del *NBN* gene mutation 24 h after irradiation with dose of 5 Gy. Chromosomal aberrations: A -- ring chromosome, B -- one chromatid break, C -- minute, D -- double minute, E -- triradial figure, F -- one chromatid break, G -- marker chromosome, H -- dicentric chromosome, I -- acentric fragment, J -- micronucleus, K -- dicentric chromosome, L -- chromatid gap](AMS-13-29240-g008){#f0008}

Discussion {#sec4}
==========

Biallelic c.657-661del mutation in the *NBN* gene in the vast majority of cases is responsible for NBS \[[@cit0011]\]. This rare disorder is characterized by chromosome instability, hypersensitivity to radiation, radioresistant DNA synthesis and high incidence of cancer development. It was found that the high incidence of haematological malignancies in NBS may be the result of the combination of a primary DSB repair deficiency and accompanying oxidative damage \[[@cit0012]\]. Deficiency in the repair of DSB leads to disturbances in cellular metabolism, leading to a loss of antioxidative capacity. Accumulation of highly reactive oxygen species results in further DNA damage, which may lead to development of malignancies \[[@cit0012], [@cit0013]\]. Although, as reported in our recent paper, we did not find that heterozygous c.657-661del, p.R215W and p.I171V mutations significantly impair nibrin function, we reported a delay in γ-H2AX foci formation and higher levels of residual foci in *NBN*-mutated cells \[[@cit0014]\]. This could indicate a defect in DSB signalling and repair. A meta-analysis based on 60 publications with a total of 39,731 cancer cases and 64,957 controls indicated that heterozygous c.657-661del, p.R215W and p.I171V mutations showed a deleterious effect on cancer susceptibility \[[@cit0005]\]. The pathogenicity of these mutations is presumably connected with their occurrence in the highly conserved BRCT (breast cancer terminal) tandem domains of nibrin, one of the major mediators of processes related to cell-cycle checkpoint and DNA repair \[[@cit0002], [@cit0005]\].

There are data on the radiosensitivity as well as the amount of nibrin in NBS cells with homo- and heterozygous c.657-661del mutations \[[@cit0011], [@cit0015]\]. To our knowledge, no data are available in the literature on *NBN* gene expression in *NBN*-mutated cells with homozygous c.657-661del and heterozygous c.657-661del, p.I171V and p.R215W mutations prior to and after irradiation. In the present study we tried to answer the following question: What is the effect of irradiation on DNA synthesis inhibition, *NBN* gene expression and chromosomal stability in lymphoblastic cell lines with germinal homozygous c.657-661del, heterozygous c.657-661del, heterozygous p.I171V and heterozygous p.R215W *NBN* gene mutations?

It was found that nibrin is involved in activation of S phase checkpoint through the mechanism regulated by ataxia telangiectasia-mutated protein kinase \[[@cit0016]\]. Before and after irradiation, cells with a homozygous c.657-661del mutation showed a higher DNA synthesis rate, measured as ^3^H thymidine as well as BrdU incorporation, than other cell lines in the 3-hour culture. In turn, the cells with heterozygous c.657-661del mutation 3 h after irradiation showed a DNA synthesis level similar to the other cell lines tested. Moreover, after irradiation the homozygous c.657-661del cell line exhibited the highest percentage of replicating cells. The results indicate that cells with a homozygous c.657-661del mutation have a significant disturbances in S phase checkpoint function and thus these cells do not decrease DNA synthesis. This observation may suggest disturbed *NBN* gene function in homozygous c.657-661del cells, whereas cells with heterozygous variants of *NBN* gene mutations (c.657-661del, p.R215W, p.I171V) reduce DNA synthesis as efficiently as control cells.

There have been no reports so far in the literature regarding *NBN* gene expression analysis in cells with homozygous c.657-661del as well as heterozygous c.657-661del, p.I171V and p.R215W mutations. In our study, primers were localized in exons 8 and 9 of the *NBN* gene, so the analysis of the expression of this gene was concerned only with the larger p70-NBN fragment of nibrin. In homozygous c.657-661del cells, it was proved that an alternative mode of translation permits production of a variant p70-NBN protein in *NBN*-mutated cells \[[@cit0017]\]. It was also reported that the p70-NBN fragment may fold independently but does not confer full function within the MRE11 complex \[[@cit0017]\].

We compared the changes in *NBN* gene expression in *NBN*-mutated cells before and after irradiation. Before irradiation, cells with homozygous and heterozygous c.657-661del and heterozygous p.I171V mutations showed lower relative *NBN* gene expression when compared to the control. Decreased expression of the *NBN* gene in cell lines with homozygous and heterozygous c.657-661del mutations might have resulted in a decrease in the amount of nibrin. That could explain why the occurrence of the above-mentioned mutations is associated with DNA repair defects. Indeed, in our study, we observed disturbed DNA synthesis inhibition and chromosomal instability in these cell lines.

It is suggested that p.I171V could have a pathogenic role, which is probably connected with its occurrence in the BRCT1 domain of the *NBN* gene \[[@cit0002], [@cit0018], [@cit0019]\]. Therefore, p.I171V could lead to perturbation in the relative geometry of tandem BRCT domains, thus impairing the delocalization of the MRN complex in the vicinity of the DNA damage site \[[@cit0007], [@cit0014]\]. However, in our study, despite decreased expression of the *NBN* gene in the p.I171V cell line, we did not observe a similar disturbance in DNA synthesis or a higher rate of chromosomal aberration.

A higher expression of the *NBN* gene, compared to the control, was only found in cells with p.R215W. It has been reported that p.R215W is associated with a lower stability of nibrin \[[@cit0020]\]. However, similar to p.171V, we did not find any disturbance of DNA synthesis or chromosomal stability in cell lines with p.R215W. A lack of these disorders in the context of a lower stability of nibrin might be explained, in our study, by significantly higher expression of *NBN* in the analysed p.R215W cell line. Higher *NBN* gene expression could probably compensate for lower stability of nibrin in p.R215W cells; thus proper functions of this protein might be preserved. Data on the effect of p.R215W on cancer susceptibility are inconsistent. Some studies have demonstrated that the p.R215W mutation is associated with elevated risk of malignancy \[[@cit0021], [@cit0022]\], whereas some authors reported no association with cancer risk \[[@cit0023], [@cit0024]\]. In a meta-analysis that included studies conducted in Caucasians (6728 cases and 9588 controls), a significant association between p.R215W occurrence and cancer risk was observed, among others, in lymphoid malignancies, astrocytic tumours and prostate cancer, but no correlation was observed with breast cancer risk \[[@cit0005]\].

*NBN* overexpression combined with neoplastic transformation and metastatic activity was observed by Wu *et al.* \[[@cit0025]\]. After irradiation, expression of *NBN* was significantly higher only in homozygous c.657-661del and heterozygous p.R215W cells, compared to heterozygous c.657-661del and p.I171V cells, as well as the control. Our observation may indicate a compensatory increase in the expression of the p70-NBN subunit in cells with homozygous c.657-661del and heterozygous p.R215W mutations. However, irradiation may in an alternative way stimulate a significantly higher increase in *NBN* gene expression in these cell lines.

Analysis of the data from the literature indicated that lower doses of irradiation (0.15 and 0.3 Gy) do not cause a distinctive difference in radiation-induced aberrations in cells with the c.657-661del mutation \[[@cit0009], [@cit0026]\]. Therefore, in this study, only the effect of a higher dose (5 Gy) of irradiation was tested. Radiosensitivity, measured as the number of chromosomal aberrations per metaphase, was significantly higher in cells with homo- and heterozygous c.657-661del mutations compared to the control cell line but was clearly marked only for the homozygous c.657-661del cell line.

In conclusion, the occurrence of the homozygous c.657-661del mutation affects cell radiosensitivity. Cell lines with homozygous c.657-661del showed the highest sensitivity to irradiation, the lowest DNA synthesis inhibition rate, changed *NBN* gene expression, as well as the highest total number of chromosomal aberrations, which indicates that this mutation is associated with disturbance in the activation of cell cycle checkpoints, defects in DNA repair mechanisms, and with higher radiosensitivity. In turn, heterozygous c.657-661del, p.R215W and p.I171V mutations do not have a significant influence on cell radiosensitivity, the DNA synthesis inhibition rate or DNA repair.

The results obtained *in vitro*, i.e., the higher radiosensitivity of c.657-661del-mutated cells, are consistent with observations of radiotherapy effects in patients with malignancies.

The source of funding for each author as well as for collection, analysis, interpretation of data and preparation of the manuscript was the National Science Centre grant no. 2011/01/B/NZ5/04322.

Conflict of interest
====================

The authors declare no conflict of interest.
